Nakamura’s Soraa lights up museum in Detroit
The Detroit Institute of the Arts opened its Arts of the Middle East Gallery, lit by full visible spectrum LED lamps from Soraa. Soraa’s GaN on GaN LED technology uses the widest range of visible color, without ultraviolet or infrared radiation that can fade or harm the art and artifacts, the company said in the announcement. Read More →
Thousand Oaks makes interim city manager permanent
After serving as interim city manager for Thousand Oaks since July 5, 2016, Andrew Powers was brought on permanently Jan. 10 in a special meeting of the Thousand Oaks City Council. Powers had previously served as assistant city manager and in community and media relations roles for Ventura and Raleigh, N.C. He received his bachelor’s Read More →
Sonos founder John MacFarlane stepping down
John MacFarlane announced Jan. 10 that he would be stepping down as CEO of the Santa Barbara audio company he founded and passing leadership of Sonos to chief operations officer Patrick Spence. “Patrick demonstrated his leadership most recently with Sonos’ success during the holiday period, but more importantly, there isn’t a person who better embodies Read More →
Limoneira reports strong revenue growth
Santa Paula agribusiness Limoneira reported increased revenues for the fourth quarter and fiscal year 2016, exceeding its guidance with an operating income of $9.2 million. Net income applicable to common stock, after preferred dividends, was $7.4 million for the year, or 52 cents per common share, up from $6.4 million in 2015. The company had announced expectations of operating Read More →
Amgen updates agreement with DaVita for dialysis treatment
Thousand Oaks biotech company Amgen entered into a six-year supply agreement with DaVita for dialysis treatments, the company announced on Jan. 9. Under the terms of the new agreement, Amgen will supply DaVita with Epogen and Aranesp for agents to stimulate red blood cells in dialysis treatment in the United States and Puerto Rico. The Read More →
Amgen partners with Immatics Biotechnologies to develop cancer drugs
Thousand Oaks biotech company Amgen formed a potential $500 million partnership with Immatics Biotechnologies GmbH to research and develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers, the company announced on Jan. 9. Under the terms of the agreement, Immatics will receive $30 million upfront and can receive more than $500 million in development, regulatory Read More →
Elings donates $4 million to Cancer Center of Santa Barbara
Philanthropist Virgil Elings donated $4 million to the new Cancer Center of Santa Barbara to open in the fall at 540 W. Pueblo St. The $53 million cancer center, which merged with Sansum Clinic in 2012, will be renamed the Ridley-Tree Cancer Center to honor Lady Leslie Ridley-Tree’s $10.73 million donation. The Elings Oncology Building Read More →
